Drawing for GRIPLAVAL

USPTO serial 85381286

GRIPLAVAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PERKINS, ELLEN J
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GRIPLAVAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angela L. Wilson

Angela L. Wilson GlaxoSmithKlineFive Moore DriveLGTM, C.3157.3DResearch Triangle Park, NC 27709

Goods and services

ClassDescriptionStatusFirst use
005VaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 23, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 23, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 25, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 24, 2014EX5GSOU EXTENSION 5 GRANTED—
Jul 18, 2014EXT5SOU EXTENSION 5 FILED—
Jul 18, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 23, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2014EX4GSOU EXTENSION 4 GRANTED—
Jan 14, 2014EXT4SOU EXTENSION 4 FILED—
Jan 14, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 27, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 25, 2013EX3GSOU EXTENSION 3 GRANTED—
Aug 21, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 22, 2013EXT3SOU EXTENSION 3 FILED—
Jul 22, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 7, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 15, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 20, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 7, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 6, 2013EX2GSOU EXTENSION 2 GRANTED—
Feb 6, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2013EXT2SOU EXTENSION 2 FILED—
Jan 24, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 12, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 10, 2012EX1GSOU EXTENSION 1 GRANTED—
Jul 10, 2012EXT1SOU EXTENSION 1 FILED—
Jul 10, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 10, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 14, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 20, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 20, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 30, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 16, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2011DOCKASSIGNED TO EXAMINER—
Jul 30, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance